Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.125 EUR | -2.48% | -10.33% | -17.50% |
Apr. 26 | Valbiotis SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 03 | Valbiotis: launch of Valbiotis PRO Cholesterol in May | CF |
Sales 2023 | 6.81M 7.4M | Sales 2024 * | 11M 11.95M | Capitalization | 65.06M 70.71M |
---|---|---|---|---|---|
Net income 2023 | -7M -7.61M | Net income 2024 * | -6M -6.52M | EV / Sales 2023 | 9.11 x |
Net cash position 2023 * | 19.83M 21.55M | Net cash position 2024 * | 18.13M 19.71M | EV / Sales 2024 * | 4.27 x |
P/E ratio 2023 * |
-4.41
x | P/E ratio 2024 * |
-4.69
x | Employees | 48 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 95.94% |
1 day | -2.48% | ||
1 week | -10.33% | ||
Current month | +0.36% | ||
1 month | +8.55% | ||
3 months | -0.60% | ||
6 months | -34.32% | ||
Current year | -17.50% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Pascal Sirvent
CTO | Chief Tech/Sci/R&D Officer | - | 17-08-31 |
Sébastien Bessy
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Agnès Tixier
BRD | Director/Board Member | - | 19-03-17 |
Laurent Lévy
CHM | Chairman | 53 | 17-02-28 |
Chief Executive Officer | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 4.125 | -2.48% | 46 114 |
24-05-16 | 4.23 | -2.87% | 32,579 |
24-05-15 | 4.355 | -0.34% | 75,890 |
24-05-14 | 4.37 | -2.67% | 32,698 |
24-05-13 | 4.49 | -2.18% | 20,187 |
Real-time Euronext Paris, May 17, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.50% | 72.52M | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- ALVAL Stock